Company: PBH
Filing Date: 2025-06-27
Form Type: DEF 14A
Source: 0001295947-25-000021
Chunk: 1

Company: Prestige Consumer Healthcare Inc.
Filing Date: 2025-06-27
Form: DEF 14A
Chunk 1
---
 |
| Appendix A                                                      |                                                                                             | 80 |
| About Non-GAAP Financial Measures                               |                                                                                             | 80 |

| IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THESTOCKHOLDERS MEETING TO BE HELD ON AUGUST 5, 2025:This Proxy Statement, the Proxy Card and the 2025 Annual Report to Stockholders are available at the “Investors” tabofwww.prestigeconsumerhealthcare.com,our internet website.You can submit a request for a copy of the proxy statement, annual report and form of proxy for any futurestockholder meetings (including the meeting of stockholders to be held on August 5, 2025) to 1-800-831-7105,(Attention: Investor Relations),proxy@prestigebrands.comor the “contact us” tab atwww.prestigeconsumerhealthcare.com.You can also contact us at the phone number, e-mail address and website set forth above to request directions to thelocation of the Annual Meeting of Stockholders so that you may attend the meeting and vote in person. |

| Prestige Consumer Healthcare Inc. | 2025 Proxy Statement |     | 5 |

COMPANY HIGHLIGHTS

About Us Who We Are: Helping Consumers Care for Themselves Prestige Consumer Healthcare Inc. is a New York Stock Exchange (“NYSE”) company that develops, manufactures, markets, sells, and distributes consumer health and personal care products in the United States, Canada, Australia, and certain other international markets. Headquartered in Tarrytown, New York, and operating with over 550 employees out of sites across the United States, Australia, Asia, and the United Kingdom, our portfolio consists of numerous well-recognized, brand-name, consumer healthcare products including:

Strategy Proven Strategy Delivers Long-Term Performance

|                                                        | Proven Ability to Execute Value Creation Strategy |                                                        |                                                                    |     |                       |
| 1Investing forGrowth with ProvenBrand-BuildingPlaybook |                                                   | 2Superior BusinessAttributes DriveStrong FreeCash Flow | 3Scalable & EfficientPlatform EnablesCapital AllocationOptionality |     | Revenue+3.4%5-Yr CAGR |

| 6 |     | 2025 Proxy Statement | Prestige Consumer Healthcare Inc. |

Company Highlights

Performance Highlights Fiscal 2025 continued our long-term track record of consistent revenue and earnings growth. We achieved record revenues, record adjusted earnings per share, and strong